Completed NA INTERVENTIONAL 3-arm NCT03505502

Reducing Blood Loss During Cesarean Myomectomy With Tranexamic Acid (TA)

Reducing Blood Loss During Cesarean Myomectomy With Intravenous Versus Topical Tranexamic Acid: a Double-blinded Randomized Placebo-controlled Trial

Sponsor: Aswan University Hospital

Conditions Cesarean Section Complications

Interventions IV tranexamic acid

Updated 7 times since 2018 Last updated: Mar 18, 2020 Started: Jan 1, 2018 Primary completion: Jan 1, 2020 Completion: Mar 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03505502, this NA trial focuses on Cesarean Section Complications and remains completed. Sponsored by Aswan University Hospital, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Apr 2020 — Jan 2021 [monthly]

Completed NA

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Apr 2020 [monthly]

Recruiting NA
May 2018 — Jun 2018 [monthly]

Recruiting NA

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aswan University Hospital

Data source: Aswan University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aswān, Egypt